摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(E)-(2,3,4-trimethoxyphenyl)methylideneamino]guanidine

中文名称
——
中文别名
——
英文名称
2-[(E)-(2,3,4-trimethoxyphenyl)methylideneamino]guanidine
英文别名
——
2-[(E)-(2,3,4-trimethoxyphenyl)methylideneamino]guanidine化学式
CAS
——
化学式
C11H16N4O3
mdl
——
分子量
252.27
InChiKey
QSZMERLTJWQUNP-MKMNVTDBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • [EN] GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE<br/>[FR] DERIVES DE GUANIDINE ET LEUR UTILISATION DANS LA PRODUCTION D'UN MEDICAMENT DESTINE A BLOQUER LES XANTHINE OXYDASES/DESHYDROGENASES
    申请人:MELACURE THERAPEUTICS AB
    公开号:WO2001025192A1
    公开(公告)日:2001-04-12
    The present invention relates to guanidine derivatives and pharmaceutically acceptable acid salts thereof. The invention further relates to pharmaceutical preparations containing said compounds, and the use of said compounds for treatment of any type of condition where the expression of xanthine oxidase/xanthine dehydrogenase enzymes is involved. The invention particularly relates to the use of these compounds in the preparation of a medicament for enhancing the survical of a transplanted cell, organ or tissue, or cell, organ or tissue to be transplanted.
    本发明涉及胍衍生物及其药用酸盐。本发明还涉及含有该化合物的制药制剂,以及使用该化合物治疗涉及黄嘌呤氧化酶/黄嘌呤脱氢酶酶表达的任何类型疾病的用途。本发明特别涉及使用这些化合物制备增强移植细胞、器官或组织的存活或待移植的细胞、器官或组织的药物。
  • Self-assembled active agents
    申请人:The United States of America, as represented by the Secretary of Agriculture
    公开号:US11166464B2
    公开(公告)日:2021-11-09
    A self-assembled active agent may be formed by a process including covalently bonding at least a first component molecule and a second component molecule, the two component molecules displaying synergy such that the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the first component molecule and the second component molecule. The component molecules may be chosen such that the covalent bonding is reversible, for example through a hydrazone bond between an amine and an aldehyde. The active agent may thus have controllable activity such as an antimicrobial agent, a biocide, an antiviral agent, a preservative, an antifouling agent, a disinfectant, or a sensor agent, such as for a particular molecule or for pH.
    自组装活性剂可通过一种工艺形成,该工艺包括至少共价键合第一组分分子和第二组分分子,这两种组分分子显示出协同作用,从而使自组装活性剂的有效量低于第一组分分子和第二组分分子的有效量之和。可以选择共价键可逆的组分分子,例如通过胺和醛之间的腙键。因此,活性剂可具有可控活性,如抗菌剂、杀菌剂、抗病毒剂、防腐剂、防污剂、消毒剂或传感剂,如针对特定分子或 pH 值的传感剂。
  • COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND WAKEFULNESS
    申请人:Chow Suk Hen
    公开号:US20150246140A1
    公开(公告)日:2015-09-03
    In some aspects, the invention relates to methods of treating conditions associated with sleep disorders, comprising administering an agent that modulates the activity of a neuropeptide receptor or a neuropeptide receptor ligand. In some aspects, the invention relates to methods of screening agents that modulate the activity of a neuropeptide receptor in an organism, optionally using cells or organisms comprising a genetic modification that affects a neuropeptide signaling pathway. In some aspects, the invention relates to methods of characterizing a condition associated with a sleep disorder comprising sequencing a nucleic acid encoding either a neuropeptide receptor or a neuropeptide receptor ligand and comparing the sequence with a reference sequence.
  • SELF-ASSEMBLED ACTIVE AGENTS
    申请人:The United States of America, as represented by the Secretary of Agriculture
    公开号:US20220015367A1
    公开(公告)日:2022-01-20
    A self-assembled active agent may be formed by a process including covalently bonding at least a first component molecule and a second component molecule, the two component molecules displaying synergy such that the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the first component molecule and the second component molecule. The component molecules may be chosen such that the covalent bonding is reversible, for example through a hydrazone bond between an amine and an aldehyde. The active agent may thus have controllable activity such as an antimicrobial agent, a biocide, an antiviral agent, a preservative, an antifouling agent, a disinfectant, or a sensor agent, such as for a particular molecule or for pH.
  • US8309609B2
    申请人:——
    公开号:US8309609B2
    公开(公告)日:2012-11-13
查看更多